3-D Bioprinting Sector

[gfp927z]

Organovo -- >>> 3 Top Jefferies New Growth Stocks to Buy With Big Upside Potential



By Lee Jackson

July 6, 2015



http://247wallst.com/investing/2015/07/06/3-top-jefferies-new-growth-stocks-to-buy-with-big-upside-potential/2/



Organovo


This stock is initiated at a Buy rating and slipped recently as a result of a secondary stock offering. Organovo Holdings Inc. (NYSEMKT: ONVO) designs and creates functional, three-dimensional human tissues for medical research and therapeutic applications. The company develops 3D human disease models through internal development and in collaboration with pharmaceutical and academic partners. Organovo believes these 3D human tissues have the potential to accelerate the drug discovery process, enabling treatments to be developed faster and at lower cost.

The Jefferies analysts feel that the company’s 3D printed human tissues offer clear advantages over current traditional methods for drug discovery and toxicology testing. They report that Organovo’s first commercial products for the liver uptake has been positive and they have been getting solid interest from top major pharmaceutical companies in recent years. The analysts also think that the liver and kidney could each be $100 million plus products on very minimal penetration.

The Jefferies price target for this very interesting but very aggressive stock is $5, and the consensus is posted at $5.33. Shares ended last week at $3.74.

<<<